Patients For Affordable Drugs is excited to name Sen. Amy Klobuchar (D-MN) as one of our January Drug Price Fighting Hero thanks to her work fighting for American patients.
Who’s funding this group anyway?
Patients For Affordable Drugs Encourages Trump Administration to Ensure Rebate Changes Benefit Patients
In anticipation of the possible elimination of safe harbor exemption for drug rebates, Patients For Affordable Drugs encouraged the Trump administration to ensure that any rebate changes benefit patients, first and foremost.
“We have an incredibly powerful, incredibly productive research and development program being run by N.I.H.,” Ameet Sarpatwari, an instructor at Harvard Medical School, said. “Taxpayers put in money that is paying big dividends, and yet we pay higher prices for prescription drugs than any other country. In effect, we have taxpayers paying twice.”